Number of the records: 1
用於治療 HIV 的喹唑啉衍生物
- 1.
SYSNO ASEP 0552007 Document Type P - Patent R&D Document Type Patent or other outcome protected by special legislation Title 用於治療 HIV 的喹唑啉衍生物 Title Quinazoline derivatives used to treat HIV Author(s) Jansa, Petr (UOCHB-X) RID
Šimon, Petr (UOCHB-X) ORCID
Lansdon, E. (US)
Hu, Y. E. (US)
Baszczyňski, Ondřej (UOCHB-X) RID, ORCID
Dejmek, Milan (UOCHB-X) RID, ORCID
Mackman, R. (US)Year of issue 2020 Possible third party use of the result A - Pro využití výsledku jiným subjektem je vždy nutné nabytí licence Royalty requested A - Poskytovatel licence požaduje licenční poplatek Patent no. or utility model no. or industrial design no. HK1244001 Date of the patent acceptance 10.01.2020 Name of the patent owner Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i Code of the issuer name CN001 - Trademark Office - State Administration for Industry and Commerce of the Peoples Republic of China (SAIC) Beijing Current use B - Patent je využíván na základě uzavřené licenční smlouvy mezi vlastníkem a uživatelem Language chi - Chinese Keywords reverse transcriptase ; reverse transcriptase ; antiviral ; NNRTI OECD category Organic chemistry Institutional support UOCHB-X - RVO:61388963 Annotation 本文描述了式 (I) 化合物的中 間互變異構體及其藥用鹽 、 含有此類化合物的組合物和製劑 ， 以及使用和製備此類化合物的方法。 Description in English Described herein are compounds of Formula (I) mid tautomers and pharmaceutical salts thereof, compositions and formulations containing such compounds, and methods of using and making such compounds. Workplace Institute of Organic Chemistry and Biochemistry Contact asep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Jana Procházková, Tel.: 220 183 418 Year of Publishing 2022 Electronic address http://hdl.handle.net/11104/0327194
Number of the records: 1